SNN

Smith & Nephew plc

Healthcare · $11.3B market cap

Verdict

Share price

$26.42

close of Oct 3, 2026

Fair value

$57.75

Sticker Price

Payback Price

$23.10

buy price

Undervalued

SNN is Undervalued: at $26.42 it trades 54% below its fair value of $57.75. Its buy price (Payback Price) is $23.10, 13% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings have been shrinking, but the business still generates cash, so we value it on its cash flow instead of its earnings.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-1.0% a year✗
Equity per share growth6.6% a year✗
Sales growth2.8% a year✗
Free cash flow growth3.5% a year✗
Return on invested capital5.9%✗

Follow SNN

Get notified when it reaches its buy price of $23.10. Free.

Create a free account

Superinvestors

1 of the investors we track holds SNN. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: Sarah Ketterer

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works